These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28533020)

  • 1. The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes.
    Guida C; Stephen S; Guitton R; Ramracheya RD
    Trends Endocrinol Metab; 2017 Aug; 28(8):626-636. PubMed ID: 28533020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYY plays a key role in the resolution of diabetes following bariatric surgery in humans.
    Guida C; Stephen SD; Watson M; Dempster N; Larraufie P; Marjot T; Cargill T; Rickers L; Pavlides M; Tomlinson J; Cobbold JFL; Zhao CM; Chen D; Gribble F; Reimann F; Gillies R; Sgromo B; Rorsman P; Ryan JD; Ramracheya RD
    EBioMedicine; 2019 Feb; 40():67-76. PubMed ID: 30639417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of gut hormone peptide YY in energy and glucose homeostasis: twelve years on.
    Manning S; Batterham RL
    Annu Rev Physiol; 2014; 76():585-608. PubMed ID: 24188711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery.
    Federico A; Dallio M; Tolone S; Gravina AG; Patrone V; Romano M; Tuccillo C; Mozzillo AL; Amoroso V; Misso G; Morelli L; Docimo L; Loguercio C
    In Vivo; 2016; 30(3):321-30. PubMed ID: 27107092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.
    Holst JJ; Madsbad S; Bojsen-Møller KN; Svane MS; Jørgensen NB; Dirksen C; Martinussen C
    Surg Obes Relat Dis; 2018 May; 14(5):708-714. PubMed ID: 29776493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in gut hormone profile and glucose homeostasis after laparoscopic sleeve gastrectomy.
    Papamargaritis D; le Roux CW; Sioka E; Koukoulis G; Tzovaras G; Zacharoulis D
    Surg Obes Relat Dis; 2013; 9(2):192-201. PubMed ID: 23183113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery.
    Holst JJ
    Curr Opin Pharmacol; 2013 Dec; 13(6):983-8. PubMed ID: 24161809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery.
    Chen X; Zhang J; Zhou Z
    Obes Surg; 2019 Sep; 29(9):3001-3009. PubMed ID: 31187459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones.
    Meek CL; Lewis HB; Reimann F; Gribble FM; Park AJ
    Peptides; 2016 Mar; 77():28-37. PubMed ID: 26344355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.
    Batterham RL; Cummings DE
    Diabetes Care; 2016 Jun; 39(6):893-901. PubMed ID: 27222547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Surgical treatment of diabetes mellitus type 2].
    Olesen SC; Hansen DL; Almdal T; Bendtsen F; Nordgaard I; Hvolris LE; Holst JJ; Naver L; Madsbad S
    Ugeskr Laeger; 2009 Feb; 171(8):615-7. PubMed ID: 19284908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLP-1 and peptide YY secretory response after fat load is impaired by insulin resistance, impaired fasting glucose and type 2 diabetes in morbidly obese subjects.
    Fernández-García JC; Murri M; Coin-Aragüez L; Alcaide J; El Bekay R; Tinahones FJ
    Clin Endocrinol (Oxf); 2014 May; 80(5):671-6. PubMed ID: 23573808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
    Ballantyne GH
    Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. News in gut-brain communication: a role of peptide YY (PYY) in human obesity and following bariatric surgery?
    Hanusch-Enserer U; Roden M
    Eur J Clin Invest; 2005 Jul; 35(7):425-30. PubMed ID: 16008543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment of type 2 diabetes mellitus].
    Carrillo-Esper R; Muciño-Bermejo MJ
    Cir Cir; 2014; 82(2):219-30. PubMed ID: 25312324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.
    Werling M; Fändriks L; Vincent RP; Cross GF; le Roux CW; Olbers T
    Surg Obes Relat Dis; 2014; 10(5):822-8. PubMed ID: 25282191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we closer to finding the treatment for type 2 diabetes mellitus in morbid obesity? Are the incretins the key to success?
    Frezza EE
    Obes Surg; 2004 Aug; 14(7):999-1005. PubMed ID: 15329192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release.
    Rodieux F; Giusti V; D'Alessio DA; Suter M; Tappy L
    Obesity (Silver Spring); 2008 Feb; 16(2):298-305. PubMed ID: 18239636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.